Biotechnology Analysis & Statistics in Israel, May 2013

You might be interested in: biotech, biomedical, biomaterials, more »

» Purchase Premium Reports

1-14 of 14 reports

Gadot Biochemical Industries Ltd. (Symbol:GDBC) SWOT Analysis, Strategy, Revenues and Profits

$ 300
Company report
March 2013
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biotechnology
Countries : Israel

OPKO Health, Inc. (OPK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2013
by Global Data

Summary OPKO Health, Inc. (OPKO), formerly eXegenics, Inc., is a US-based pharmaceutical and health care service provide. It operates in the diagnostics and pharmaceutical markets. The company is involved ...

Industries : Genomics
Countries : United States, Israel, World

Prolor Biotech, Inc. (PBTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
March 2013
by Global Data

Summary PROLOR Biotech, Inc. (Prolor), formerly Modigene Inc., is a development stage biopharmaceutical company. It focuses on developing longer-lasting, proprietary versions of already approved therapeutic ...

Industries : Biopharmaceutical
Countries : United States, Israel

XTL Biopharmaceuticals Ltd. (XTLBY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
February 2013
by Global Data

Summary XTL Biopharmaceuticals Ltd. (XTL) is a biotechnology company, based in Israel. The company acquires, develops and commercializes therapeutics for the treatment of multiple myeloma and hepatitis ...

Industries : Biopharmaceutical
Countries : Israel

DNAPrint Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$ 250
Company report
August 2012
by Global Data

DNAPrint Genomics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary DNAPrint Genomics, Inc. (DNAPrint Genomics) is a medical device company which is focused on the development ...

Industries : Genomics
Countries : United States, Canada, Israel

European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries) - Executive Summary only

$ 195
Industry report
March 2012
by iData Research, Inc.

In 2011, the European markets for bone graft substitute, dental membranes and tissue engineering products approached ?248 million. - Austria, - Benelux (comprising Belgium, the Netherlands and Luxemburg), ...

Industries : Biomaterial
Countries : Europe, Czech Republic, World, United Kingdom, Switzerland, Netherlands, Sweden, Spain, Romania, Portugal, Poland, Norway, Italy, Greece, France, Germany, Finland, Denmark, Belgium, Austria, Israel

Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report

$ 125
Company report
February 2012
by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile ...

Industries : Biopharmaceutical
Countries : United States, Israel

Delving into Stem Cell Research and its Potential

$ 350
Industry report
January 2012
by Aruvian's R'search

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...

Industries : Biological Therapy
Countries : World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China

Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis

$ 99
Company report
September 2011
by ICD Research

Synopsis ICD Research's "Omrix Biopharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, ...

Industries : Biopharmaceutical
Countries : United States, Israel

Biopharmaceutical Industry: Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011

$ 500
Company report
March 2011
by Global Markets Direct

This report provides data on the therapeutic development for Acromegaly And Gigantism (Growth Hormone Disorders), complete with latest updates, and special features on late-stage and discontinued projects. ...

Industries : Biological Therapy
Countries : Israel, World

Biopharmaceutical Industry: Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

This report provides data on the therapeutic development for Acromegaly and Gigantism , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

Industries : Biological Therapy
Countries : Israel, World

Global Lou Gehrig's Disease industry

$ 3 450
Industry report
April 2010
by Global Industry Analyst

This report analyzes the Global market for Lou Gehrig's Disease in US$ Million. Annual estimates and forecasts are provided for the period 2006 through 2015. The report profiles 37 companies including ...

Industries : Biological Therapy
Countries : World, United States, Canada, Australia, United Kingdom, France, Germany, Europe, North America, New Zealand, Oceania, Sweden, Taiwan, Israel

A Quick Guide to Biotechnology and Healthcare in the Middle East

$ 148
Industry report
April 2009
by BioPlan Associates, Inc.

Healthcare is a universal right and regardless of region, everyone in the world should benefit from the advances that have been made in modern medicine. The Middle East is no exception. This book aims ...

Industries : Biopharmaceutical, Biotechnology, Healthcare
Countries : Saudi Arabia, Asia, World, Yemen, Syrian Arab Republic, Qatar, Lebanon, Kuwait, Jordan, Israel, Bahrain, Egypt

Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis

$ 2 925
Industry report
August 2008
by Bioseeker

This report aims to analyze the current and future potential of breast cancer pipeline by examining key fundamentals across the entire pipeline of drug candidates. The author has identified three fundamental ...

Industries : Drug Discovery and Development, Biotechnology
Countries : South Korea, Europe, New Zealand, Australia, United Kingdom, Switzerland, Netherlands, World, Canada, Sweden, Norway, Italy, Ireland, France, Germany, Finland, Denmark, Austria, Japan, Israel, India, China

... And (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (v) residential projects - initiation, construction ...